Diseases, Conditions, Syndromes

COVID-19 antibody 'cocktail' protects chronically ill: study

A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a study of immunocompromised and chronically ill adults ...

Diseases, Conditions, Syndromes

Coronavirus: why we're using llamas to help fight the pandemic

The search is on for effective treatments to combat the unprecedented COVID-19 pandemic. Given the lengthy development process for vaccines, one major immediate priority is the development of selective antibodies that can ...

Diseases, Conditions, Syndromes

High doses of antiviral drug may be effective against Ebola

High doses of favipiravir extended survival in non-human primates infected with Ebola virus, according to a new study published this week in PLOS Medicine by Jeremie Guedj of INSERM, France, and colleagues.

page 1 from 2